Global postpartum treatment device market is anticipated to rise with a CAGR of about 6.4% for the forecast period of 2021-2030. Rising prevalence of postpartum hemorrhage has boosted the demand for postpartum hemorrhage treatment devices. About 14 million women gets affected from postpartum hemorrhage every year as per WHO. About 1 in every 100 woman suffer from the postpartum hemorrhage globally and more than 220 women bleed to death per day. Approximately 287000 mortality figure are recorded in pregnancy and child birth due to excessive bleeding. This has increased the demand for the treatment devices and drugs globally.
According to national statistics, nearly about 8% of deaths caused by postpartum hemorrhage PPH ranks in the top 3 causes of maternal mortality. More than 60% of population of women is suffering from amnesia which is a major cause of postpartum hemorrhage. According to world health organization, 275000 women die every year due to pregnancies and childbirths. As such postpartum hemorrhage is a major health issue because of majority maternal deaths (88%), which occur within four hour of delivery due of postpartum hemorrhage. High prevalence of postpartum hemorrhage 25.7% reported in Africa, 21.5% recorded in East Africa and 14.3% reported in Nigeria.
Browse full report at : https://www.atlanticmarketresearch.com/post-partum-hemorrhage-pph-treatment-device-market
The uterine balloon tamponade segment is a leading market among the type of devices with a market share of 45.35% and its dominance is expected to continue during the forecast period. Increasing adoption of uterine balloon tamponade in developing region and high effectiveness and success rates of UBT has helped to fuel the growth in the market. Success rate of 84% has been reported with the use of various balloons including Bakri balloon, Foley catheters and Condom catheters.
Geographically the market has been bifurcated into four regions that includes North America, Asia Pacific, Europe and rest of the world. North American region dominates the market with a total share of about 37.35% as of year 2020. Presence of developed countries such as US and Canada helps to fuel the market of North American region. Moreover, Asia Pacific region has been determined as a fastest growing region with a CAGR of about 6.9% during the forecast year 2021-2030.
Global postpartum hemorrhage (PPH) treatment devices market is exceedingly consolidated, as it has huge number of companies globally. Globally, there are few players are operating in these markets. Furthermore, these companies are competitive in nature. Some major companies involved in postpartum hemorrhage (PPH) treatment devices are; Teleflex incorporated, Beckton Dickinson, C.R. Bard Inc., Cook Medical Incorporated, Davol a Rhode and many others. All these contributes for more than 40% of the total market revenue.
KEY MARKET MOVEMENTS
- Global postpartum treatment device market is anticipated to rise with a CAGR of about 6.4% for the forecast period of 2021-2030.
- The uterine balloon tamponade segment is a leading market among the type of devices with a market share of 45.35% and its dominance is expected to continue during the forecast period.
- North American region dominates the market with a total share of about 37.35% as of year 2020.
- Asia Pacific region has been determined as a fastest growing region with a CAGR of about 6.9% during the forecast year 2021-2030.
- Global postpartum hemorrhage (PPH) treatment devices market is exceedingly consolidated, as it has huge number of companies globally.
- Some major companies involved in postpartum hemorrhage (PPH) treatment devices are; Teleflex incorporated, Beckton Dickinson, C.R. Bard Inc., Cook Medical Incorporated, Davol a Rhode and many others.
